A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Summary

The study will assess the safety and efficacy of QGE031 in the treatment of moderate to severe atopic dermatitis patients. In addition, QGE031 levels in the blood will be measured and the effect of QGE031 on markers in the blood and skin will be evaluated. Comparisons of the effect of QGE31 will be made with placebo and also cyclosporine, a treatment already established as being effective in atopic dermatitis.

Timeline

Start

2012-01-05

Primary completion

2013-08-28

Completion

2013-08-28

Drugs

Indications